BackAnti-Microbial Savior BioteQ , Ltd Overview

Anti-Microbial Savior BioteQ , Ltd Current Assets

Track Anti-Microbial Savior BioteQ , Ltd's current assets ($420M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$416.92M
↑ 167.03% YoYΔ $260.79M vs prior year quarter

Peer trimmed avg / median

Loading

Anti-Microbial Savior BioteQ , Ltd Current Assets History

Loading

Anti-Microbial Savior BioteQ , Ltd vs. peers: Current Assets Comparison

Loading

Anti-Microbial Savior BioteQ , Ltd Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Anti-Microbial Savior BioteQ , Ltd (6864.TWO) FAQ

Anti-Microbial Savior BioteQ , Ltd's current assets stands at $420M as of June 2026. That compares with $160M in the prior-year period — up 167.0% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Anti-Microbial Savior BioteQ , Ltd reported $420M in current assets versus $160M a year earlier — a 167.0% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $160M in the prior-year period — up 167.0% year over year. Sustained growth in current assets can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Anti-Microbial Savior BioteQ , Ltd's current assets evolved across reporting periods, while the comparison chart places 6864.TWO next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, current assets is commonly used to spot outliers. Anti-Microbial Savior BioteQ , Ltd's reading of $420M is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.